Seymour L - Search Results

1

'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study Group.

Cunningham D, Zalcberg J, Smith I, Gore M, Pazdur R, Burris H 3rd, Meropol NJ, Kennealey G, Seymour L. Cunningham D, et al. Among authors: seymour l. Ann Oncol. 1996 Feb;7(2):179-82. doi: 10.1093/oxfordjournals.annonc.a010546. Ann Oncol. 1996. PMID: 8777175 Free article. Clinical Trial.

2

A phase II study of Tomudex in relapsed epithelial ovarian cancer.

Gore ME, Earl HM, Cassidy J, Tattersall M, Mansi J, Seymour L, Azab M. Gore ME, et al. Among authors: seymour l. Ann Oncol. 1995 Sep;6(7):724-5. doi: 10.1093/oxfordjournals.annonc.a059291. Ann Oncol. 1995. PMID: 8664196 Free article. Clinical Trial. No abstract available.

3

A phase II study in advanced breast cancer: ZD1694 ('Tomudex') a novel direct and specific thymidylate synthase inhibitor.

Smith I, Jones A, Spielmann M, Namer M, Green MD, Bonneterre J, Wander HE, Hatschek T, Wilking N, Zalcberg J, Spiers J, Seymour L. Smith I, et al. Among authors: seymour l. Br J Cancer. 1996 Aug;74(3):479-81. doi: 10.1038/bjc.1996.386. Br J Cancer. 1996. PMID: 8695369 Free PMC article. Clinical Trial.

4

A phase II study of raltitrexed ('Tomudex') in patients with hepatocellular carcinoma.

Rougier P, Ducreux M, Kerr D, Carr BI, François E, Adenis A, Seymour L. Rougier P, et al. Among authors: seymour l. Ann Oncol. 1997 May;8(5):500-2. doi: 10.1023/a:1008249328792. Ann Oncol. 1997. PMID: 9233532 Free article. Clinical Trial. No abstract available.

5

Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study Group.

Zalcberg J, Kerr D, Seymour L, Palmer M. Zalcberg J, et al. Among authors: seymour l. Eur J Cancer. 1998 Nov;34(12):1871-5. doi: 10.1016/s0959-8049(98)00259-7. Eur J Cancer. 1998. PMID: 10023308 Clinical Trial.

6

A phase I dose escalation study of the matrix metalloproteinase inhibitor BAY 12-9566 administered orally in patients with advanced solid tumours.

Hirte H, Goel R, Major P, Seymour L, Huan S, Stewart D, Yau J, Arnold A, Holohan S, Waterfield B, Bates S, Bennett K, Walsh W, Elias I. Hirte H, et al. Among authors: seymour l. Ann Oncol. 2000 Dec;11(12):1579-84. doi: 10.1023/a:1008347630465. Ann Oncol. 2000. PMID: 11205466 Free article. Clinical Trial.

7

A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.

Knowling M, Browman G, Siu L, Khoo K, Cooke A, Tannock I, Klaassen D, Cripps C, Goss G, Matthews S, Clarke R, Seymour L. Knowling M, et al. Among authors: seymour l. Ann Oncol. 2001 Jul;12(7):919-22. doi: 10.1023/a:1011141530545. Ann Oncol. 2001. PMID: 11521795 Free article. Clinical Trial.

8

A phase II study of ZD0473 given as a short infusion every 3 weeks to patients with advanced or metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group trial, IND 129.

Gelmon KA, Vandenberg TA, Panasci L, Norris B, Crump M, Douglas L, Walsh W, Matthews SJ, Seymour LK. Gelmon KA, et al. Among authors: seymour lk. Ann Oncol. 2003 Apr;14(4):543-8. doi: 10.1093/annonc/mdg171. Ann Oncol. 2003. PMID: 12649098 Free article. Clinical Trial.

9

Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115.

Maroun JA, Belanger K, Seymour L, Matthews S, Roach J, Dionne J, Soulieres D, Stewart D, Goel R, Charpentier D, Goss G, Tomiak E, Yau J, Jimeno J, Chiritescu G; National Cancer Institute of Canada Clinical Trials Group. Maroun JA, et al. Among authors: seymour l. Ann Oncol. 2006 Sep;17(9):1371-8. doi: 10.1093/annonc/mdl165. Ann Oncol. 2006. PMID: 16966366 Free article. Clinical Trial.

10

Phase II trial of raltitrexed ('Tomudex') in advanced small-cell lung cancer.

Woll PJ, Basser R, Le Chevalier T, Drings P, Perez Manga G, Adenis A, Seymour L, Smith F, Thatcher N. Woll PJ, et al. Among authors: seymour l. Br J Cancer. 1997;76(2):264-5. doi: 10.1038/bjc.1997.373. Br J Cancer. 1997. PMID: 9231930 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

545 results

Search Page